Free Newsletter
Better modeling to reduce animal testing
Drug testing via computer modeling, virtual tissue, and human and animal cells are helping the pharma industry move away from the use of animals as primary test subjects.
Researchers recruit tens of millions of animals annually for drug testing, reports The Baltimore Sun. Eighty to 800 are needed per drug.
Robert Kavlock, director at the EPA's National Center for Computational Toxicology, says animals represent the current "gold standard" in drug testing, according to the article. "But there is a collective recognition that we need to do better." And there are solid practical reasons to move away from the use of animals. A chemical that costs $6 million to $10 million to test might yield computer test results for "more like $20,000."
- here's the article
Related Article:
FDA, Tox21 try IT in place of animal tests
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: